While we are continuing to see a significant decline in monkeypox cases in the U.S., upper respiratory diseases, including influenza, COVID, and RSV are increasing.
COVID cases are continuing to decline in the U.S., however we are beginning to see some increased activity with new variants, particularly BQ.1 and BQ.1.1.
Key Points: COVID In today’s Recommendation for Industry, we discuss the globally increasing respiratory diseases, which we see as likely attributable to annual seasonal trends.
Key Points: COVID In today’s Recommendation for Industry, we discuss the expected fall increase in respiratory illnesses. Read more below. COVID vaccines in pregnancy tied
Key Points: COVID In today’s Recommendation for Industry, we discuss the overall positive trajectory of COVID cases, even with variants continuing to emerge. Read more
Key Points: COVID In today’s Recommendation for Industry, we discuss TAG’s weekly updates on infectious disease and some further advice in reducing norovirus transmission. Read
Key Points: COVID In today’s Recommendation for Industry, we discuss the status of COVID, monkeypox and the flu, and the continuing evolution of TAG’s matrices
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines.
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains
